These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31782436)
21. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery. Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866 [TBL] [Abstract][Full Text] [Related]
22. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575 [TBL] [Abstract][Full Text] [Related]
23. Photoluminescent carbon nanotags from harmful cyanobacteria for drug delivery and imaging in cancer cells. Lee HU; Park SY; Park ES; Son B; Lee SC; Lee JW; Lee YC; Kang KS; Kim MI; Park HG; Choi S; Huh YS; Lee SY; Lee KB; Oh YK; Lee J Sci Rep; 2014 Apr; 4():4665. PubMed ID: 24721805 [TBL] [Abstract][Full Text] [Related]
24. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery. Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516 [TBL] [Abstract][Full Text] [Related]
25. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090 [TBL] [Abstract][Full Text] [Related]
26. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
27. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells. He X; Hai L; Su J; Wang K; Wu X Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439 [TBL] [Abstract][Full Text] [Related]
28. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma. Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125 [TBL] [Abstract][Full Text] [Related]
29. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles. Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571 [TBL] [Abstract][Full Text] [Related]
30. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764 [TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer. Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081 [TBL] [Abstract][Full Text] [Related]
32. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects. Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830 [TBL] [Abstract][Full Text] [Related]
33. Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy. Xuan M; Shao J; Dai L; He Q; Li J Adv Healthc Mater; 2015 Aug; 4(11):1645-52. PubMed ID: 25960053 [TBL] [Abstract][Full Text] [Related]
34. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo. Liu Y; Ding X; Li J; Luo Z; Hu Y; Liu J; Dai L; Zhou J; Hou C; Cai K Nanotechnology; 2015 Apr; 26(14):145102. PubMed ID: 25789511 [TBL] [Abstract][Full Text] [Related]
35. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726 [TBL] [Abstract][Full Text] [Related]
36. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer. Yang R; Hou M; Gao Y; Zhang L; Xu Z; Kang Y; Xue P Nanoscale; 2019 Mar; 11(12):5717-5731. PubMed ID: 30865744 [TBL] [Abstract][Full Text] [Related]
37. Multifunctional NaYF4:Yb, Er@mSiO2@Fe3O4-PEG nanoparticles for UCL/MR bioimaging and magnetically targeted drug delivery. Liu B; Li C; Ma P; Chen Y; Zhang Y; Hou Z; Huang S; Lin J Nanoscale; 2015 Feb; 7(5):1839-48. PubMed ID: 25521795 [TBL] [Abstract][Full Text] [Related]